Analysis of CoolSculpting by Zeltiq for Non-Invasive Cooling of Abdominal Fat Using the eZ App Large Applicator
Sponsored by Laser and Skin Surgery Center of New York
About this trial
Last updated 10 years ago
Study ID
Status
Type
Placebo
Accepting
Trial Timing
Ended 13 years ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
- Male or female between the ages of 18 and 65 years of age.
- Clearly visible fat on an area of the lower abdomen appropriate for treatment with the non-invasive Zeltiq cooling device.
- Not had weight change fluctuations exceeding 5 pounds in the preceding 6 months.
- Read and sign a written informed consent form.
Exclusion Criteria
- Had liposuction, or another surgical procedure(s) or mesotherapy (injections of minute natural extracts, drugs and other agents into the skin to eliminate fat deposits in cellulite) in area of intended treatment within the past 2 years.
- Had treatment with a cooling device within the past 6 months. (This exclusion does not apply to those enrolled in Group 3).
- Known history of injections into the abdomen (e.g., cortisone) within the past 6 months.
- Known history of cryoglobulinemia (abnormal blood proteins that thicken in cold temperatures), cold urticaria (large, allergic hives that occur when the skin is exposed to cold), or paroxysmal cold hemoglobinuria (sudden development of red blood cell breakdown causing hemoglobin [protein compound in blood] in the urine).
- Used diet pills within the past 6 months.
- Taking amino- or theophylline for asthma.
- You are unable or unwilling to comply with the study requirements.
- Any dermatological conditions or scars within the location of the treatment site that may interfere with the treatment or evaluation.
- Currently enrolled in a clinical study of any other unapproved investigational drug or device.
- Pregnant or intending to become pregnant in the next 9 months.
- Breastfeeding or have been breastfeeding in the past 9 months.
- Any other condition that would, in the professional opinion of the study doctor, potentially affect response or participation in this clinical study, or would pose an unacceptable risk to the subject.